DL-Allylglycine

DL-Allylglycine is a DL mixture of the α-amino acid allylglycine, featuring a stereogenic center at the alanine-like backbone and a pendant allyl side chain that contains a terminal alkene. The molecule bears both an amino functionality and a carboxylic acid (or, depending on salt/derivative form used in synthesis), enabling conversion into protected amino acid derivatives for peptide chemistry and into activated intermediates for side-chain functionalization. The allyl group can participate in alkene-selective transformations such as halogenation, epoxidation, metathesis, or radical-mediated functional group installation, while the amino acid backbone supports amide bond formation after appropriate protection and activation. The DL stereochemical composition makes it suitable for building blocks where racemic incorporation is acceptable, including method development, derivatization studies, and intermediate preparation for downstream chiral resolution or stereochemical diversification.

1. Peptide Synthesis

DL-Allylglycine can be employed as a peptide building block in solid-phase or solution-phase peptide synthesis when racemic side-chain incorporation is acceptable for library generation or method development. The α-amino acid backbone supports N-protection strategies (e.g., carbamate or amide-type protection) and subsequent coupling through standard peptide coupling chemistry after carboxyl activation, while the allyl side chain remains available for post-coupling modification. Allyl-bearing residues can be used to generate peptide analogs bearing reactive handles for later derivatization, including alkene functionalization to introduce hydroxyl, halide, or other substituents that alter polarity and binding properties. Downstream, DL-Allylglycine-derived peptides can serve as intermediates for peptidomimetic construction and as scaffold material for structure-activity relationship studies that probe side-chain substitution effects.

2. Side-Chain Functionalization

DL-Allylglycine is well suited for synthetic organic chemistry workflows that leverage the terminal alkene on the side chain to access functionalized amino acid derivatives. The allyl group can undergo chemoselective transformations to install additional functional groups while the amino acid functionality can be protected to control reactivity during multi-step sequences. N- and C-terminal protection strategies enable sequential chemistry in which the alkene is modified first and the amino acid is later converted into protected amino acid esters, activated acids, or coupling-ready derivatives. Resulting allyl-to-functionalized products can be used as intermediates for further amino acid derivatization, including preparation of electrophilic or nucleophilic side-chain variants used in peptide coupling, biomolecule modification, and fine chemical synthesis.

3. Chiral Resolution Intermediates

DL-Allylglycine can function as a racemic chiral amino acid intermediate for downstream stereochemical diversification, including routes that separate enantiomers or convert the racemate into diastereomerically enriched derivatives. The presence of a single stereogenic center at the α-position allows formation of diastereomeric salts or derivatives with chiral auxiliaries, enabling analytical and preparative workflows that target enantiopure allylglycine analogs. The allyl side chain provides an orthogonal functional handle for derivatization after stereochemical enrichment, allowing conversion into enantiopure building blocks for subsequent peptide construction or side-chain elaboration. This makes DL-Allylglycine relevant to chiral synthesis planning in which racemic starting material is used to generate enantiopure amino acid derivatives for stereodefined research and manufacturing intermediates.

4. Chemical Biology Labeling

DL-Allylglycine can be applied in chemical biology and biomolecule modification strategies that require an alkene-bearing amino acid residue for post-incorporation tagging chemistry. The amino acid backbone supports conversion into protected derivatives that can be incorporated into peptides or used to prepare amino acid conjugates, while the allyl side chain provides a reactive locus for alkene-selective labeling or secondary functional group installation. Protecting-group control enables selective deprotection to reveal coupling sites without perturbing the alkene, supporting sequential conjugation and downstream derivatization of the labeled biomolecule. Allyl-functionalized amino acid motifs derived from DL-Allylglycine may serve as intermediates for generating probe libraries, mapping experiments, or assay reagents where controlled side-chain chemistry is required.

5. Process Chemistry Intermediates

DL-Allylglycine is suitable for process chemistry intermediate preparation due to its straightforward amino acid functionality and the chemical handle provided by the allyl side chain. The amino acid core can be converted into protected amino acid derivatives, activated esters, or coupling-ready intermediates using protection and activation sequences that are compatible with scale-up planning in fine chemical manufacturing. The terminal alkene enables downstream transformation into more stable or more reactive intermediates (e.g., epoxide or halide analogs) that can feed into subsequent synthesis steps for specialty chemicals and peptide-related materials. Racemic availability can simplify supply-chain considerations for manufacturing of non-stereospecific intermediates, while stereochemical enrichment can be introduced later if required by the target application.

6. Analytical Research Standards

DL-Allylglycine can be utilized in analytical research as a reference material for method development involving amino acid derivatization, chiral analysis, and alkene-functional compound profiling. The combination of an amino acid backbone and an allyl side chain supports derivatization workflows that enable chromatographic detection and mass spectrometric characterization of amino acid derivatives and their transformations. Racemic composition provides a practical standard for validating racemate-resolving methods, monitoring stereochemical separation performance, and calibrating analytical response for allylglycine-related species. Allyl-specific derivatization products can also serve as secondary standards for confirming alkene conversion and for tracking side-chain functionalization steps in peptide building block synthesis and downstream intermediate preparation.

1. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes

2. Multifunctional peptide-oligonucleotide conjugate promoted sensitive electrochemical biosensing of cardiac troponin I

3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

4. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active

5. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum